E13.353
Other specified diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code E13.353 refers to a specific type of diabetes mellitus characterized by a complication affecting the eyes, known as proliferative diabetic retinopathy (PDR). This condition involves abnormal blood vessel growth in the retina, which can lead to a serious eye problem called traction retinal detachment, particularly when it does not involve the central part of the retina called the macula. Understanding this condition helps in appreciating the potential challenges faced by individuals with this diagnosis and the importance of eye health management in diabetes.
Causes & Symptoms
Clinical Causes: Chronic high blood sugar levels from poorly controlled diabetes Progression of diabetic retinopathy due to ongoing microvascular damage Growth of fragile new blood vessels in the retina that can cause complications Development of tractional forces exerted by fibrous tissue on the retina Long-standing diabetes increasing risk of eye-related complications
Key Symptoms: Blurred or distorted vision Floaters or spots in the field of vision Reduced visual acuity in affected eye Possible absence of noticeable symptoms until the condition advances Possible visual field loss if detachment occurs
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a comprehensive eye examination by an ophthalmologist, including dilated retinal examination and imaging techniques such as fundus photography and optical coherence tomography (OCT). These tests help identify abnormal blood vessel growth, scarring, and retinal detachment. Fluorescein angiography may also be used to assess blood vessel leakage and proliferation in the retina.
Treatment Protocols: Management of proliferative diabetic retinopathy with traction retinal detachment often involves procedures aimed at preventing further vision loss and restoring retinal integrity. Common treatments include: - **Laser photocoagulation** to halt abnormal blood vessel growth and prevent further bleeding - **Vitrectomy**, a surgical procedure to remove the vitreous gel and scar tissue contributing to traction - **Anti-VEGF injections**, medications to inhibit vascular endothelial growth factor and reduce abnormal vessel formation - Ongoing management of blood sugar levels to control diabetes and prevent progression Early detection and timely treatment are key to preserving vision in affected individuals.
Clinical Advice & FAQs
Billing Guidance
Is E13.353 a billable ICD-10 code?
Yes, E13.353 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E13.353?
Clinical documentation must specify the nature of Other specified diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula and any associated comorbidities for accurate reporting.
Cite this Clinical Reference